Q) GNRH agonist is
A. Buserelin
B. Anastrazole,
C. Exemestane,
D. letrozole
Q) GNRH agonist is
A. Buserelin
B. Anastrazole,
C. Exemestane,
D. letrozole
Q) WHIch group of lymph nodes not removed in two field Lymph node dissection in lower esophageal Carcinoma
a) Brachiocephalic
b) coeliac
c) left gastric
d) Lower mediastinal
Other Questions on Esophagus
Q ) 45 year old patient with jaundice and itching diagnosed with adenocarcinoma of carcinoma head of pancreas with ECOG 1 , total bilirubin 10mg% , s calcium 6.3 , sgot sgpt deranged. What is management
a) Whipple
b) Stenting whiple
c) Triple bypass
d) Biopsy stenting Chemo
Q High grade Mucoepidermoid carcinoma with VII nerve palsy. Next line of management will be
A. Surgery and chemo radiotheraoy
B. Chemotherapy
C. Radiotheray
D. Surgery followed by RT
Q) Not an important prognostic factor in Carcinoma thyroid (JIPMER)
A. Age
B. Completeness of resection
C. Multicentricity
D. Extra thyroid extension
Q) Paraneoplastic syndrome with small cell lung carcinoma
a) SIADH
b) Cushings
c) Hypercalcemia
Q) What is not a clinical feature of malignant conversion of salivary gland tumor?
a) Pain
b) Facial nerve weakness
c) Swelling
d) Cervical lymph node swelling
More Questions Head and Neck onco
Q) What is the definitive management option for the superior vena cava syndrome?
A)Bed rest and oxygen administration
B)Diuretic therapy
C)Prophylactic anticoagulant
D)Removal of the underlying malignancy
Q) Medullary carcinoma thyroid, what test is not done (NEET 2019)
a) Calcitonin
b) Glucagon
c) VMA
d) CEA
Click below to chat on WhatsApp or send an email to adam@mcqsurgery.com